PL405376A1 - Modified protoescigenin derivatives - Google Patents

Modified protoescigenin derivatives

Info

Publication number
PL405376A1
PL405376A1 PL405376A PL40537613A PL405376A1 PL 405376 A1 PL405376 A1 PL 405376A1 PL 405376 A PL405376 A PL 405376A PL 40537613 A PL40537613 A PL 40537613A PL 405376 A1 PL405376 A1 PL 405376A1
Authority
PL
Poland
Prior art keywords
derivatives
protoescigenin
modified
group
formula
Prior art date
Application number
PL405376A
Other languages
Polish (pl)
Inventor
Kamil Jatczak
Mariusz Gruza
Bogdan Zagrodzki
Piotr Cmoch
Katarzyna Koziak
Grzegorz Grynkiewicz
Original Assignee
Instytut Farmaceutyczny
Warszawski Uniwersytet Medyczny
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Instytut Farmaceutyczny, Warszawski Uniwersytet Medyczny filed Critical Instytut Farmaceutyczny
Priority to PL405376A priority Critical patent/PL405376A1/en
Publication of PL405376A1 publication Critical patent/PL405376A1/en

Links

Landscapes

  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Pochodne 3,24;16,22-O,O;O,O-diizopropylideno-protoescygeniny o wzorze (I), w którym jeden z podstawników R1 i R2 oznacza H, a drugi grupę 2-propynylową lub grupę o wzorze (II), gdzie R oznacza grupę piranozydową R przyłączoną do atomu tlenu w pozycji C21 lub C28 poprzez linker triazolowy. 3.24; 16,22-O, O; O, O-diisopropylidene-protocygenine derivatives of formula (I), wherein one of R1 and R2 is H and the other is a 2-propynyl group or a group of formula (II) where R is a pyranoside group R attached to the oxygen at C21 or C28 via a triazole linker.

PL405376A 2013-09-16 2013-09-16 Modified protoescigenin derivatives PL405376A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL405376A PL405376A1 (en) 2013-09-16 2013-09-16 Modified protoescigenin derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL405376A PL405376A1 (en) 2013-09-16 2013-09-16 Modified protoescigenin derivatives

Publications (1)

Publication Number Publication Date
PL405376A1 true PL405376A1 (en) 2015-03-30

Family

ID=52727634

Family Applications (1)

Application Number Title Priority Date Filing Date
PL405376A PL405376A1 (en) 2013-09-16 2013-09-16 Modified protoescigenin derivatives

Country Status (1)

Country Link
PL (1) PL405376A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016135553A1 (en) 2015-02-27 2016-09-01 Warszawski Uniwersytet Medyczny Protoescigenin derivative, process of its preparation, use of said compound and pharmaceutical composition comprising that compound

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016135553A1 (en) 2015-02-27 2016-09-01 Warszawski Uniwersytet Medyczny Protoescigenin derivative, process of its preparation, use of said compound and pharmaceutical composition comprising that compound

Similar Documents

Publication Publication Date Title
BR112015020795A2 (en) new pyrazole derivatives
CR20150661A (en) COMPOUNDS OF N- (TETRAZOL-5-IL) - AND N- (TRIAZOL-5-IL) SUBSTITUTED ARILCARBOXAMIDE AND ITS USE AS HERBICIDES
UA108101C2 (en) N3-substituted N1-sulfonyl-5-fluoropyrimidinone derivatives
AR089818A1 (en) QUINASE INHIBITOR REGULATING THE APOPTOSIS SIGNAL
EA201591503A1 (en) NAFTHYRIDINE DERIVATIVES, USEFUL AS ANTAGONISTS ALPHA-V-BETA-6 INTEGRINA
JO3515B1 (en) Pyrimidine fgfr4 inhibitors
EA201590854A1 (en) Pyridine-2-amides, suitable as agonists of cannabinoid receptor 2
MA44820B1 (en) Heterocyclic amides for use as kinase inhibitors
UA110880C2 (en) Substituted amides nose beta-lacto, production and use thereof as antibacterials
ATE554066T1 (en) ANTI-INFLAMMATORY SUBSTITUTED CYCLOBUTENDIONE COMPOUNDS
TR201809417T4 (en) Purine derivatives as Cb2 receptor agonists.
AR097866A1 (en) 4-AZAINDOL DERIVATIVES
BR112015029348A2 (en) bace inhibitors
UA106889C2 (en) N1-ACYL-5-FLORPYRIMIDINONE DERIVATIVES
BR112013004624A2 (en) "furopiridine derivatives"
EA201691982A1 (en) 5,6-Disposable Pyridine-2-Carboxamides as Agonists of Cannabinoid Receptors
UA106880C2 (en) NEW HERBICIDES
UA116801C2 (en) PORIMIDINE PORIMAL [2,3-d] PIRIMIDINE AS CB2 receptor agonists
PH12015502462A1 (en) Imidazo-triazine derivatives as pde10 inhibitors
AR091888A1 (en) UREA COMPOUNDS AND ITS USE AS ENZYMES INHIBITORS
MX2015013740A (en) Pyrazolonaphthyridinone derivatives as metap2 inhibitors (methionine aminopeptidase type-2).
EA033155B1 (en) Herbicidally active n-(tetrazole-5-yl)aryl carboxamide derivatives
CL2019000487A1 (en) Triazolopyrazinone derivative useful as a human pde1 inhibitor.
CR20160146A (en) DERIVATIVES OF UREA INDOL REPLACED WITH GLUCOPIRANOSIL AND ITS USE AS SGLT INHIBITORS
MX2015009377A (en) Radiolabeled compounds.

Legal Events

Date Code Title Description
DISC Decisions on discontinuance of the proceedings (taken after the publication of the particulars of the applications)